These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8285946)

  • 1. Shorter treatment courses or larger daily doses?
    Healy JB
    Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):484-5. PubMed ID: 8285946
    [No Abstract]   [Full Text] [Related]  

  • 2. [Roentgentherapy with massive and spaced doses].
    Zarandieta JG; Cervantes Nicolas JJ
    J Radiol Electrol Med Nucl; 1970; 51(3):159-61. PubMed ID: 5503070
    [No Abstract]   [Full Text] [Related]  

  • 3. [High doses of radiotherapy in the treatment of pharyngolaryngeal neoplasms].
    Jiménez-Cervantes Nico ; García Zarandieta J; Avellán Fernández G
    Acta Otorinolaryngol Iber Am; 1969; 20(1):87-95. PubMed ID: 5791865
    [No Abstract]   [Full Text] [Related]  

  • 4. [The connection between clinical stage and dosetime ratio in laryngeal cancer (author's transl)].
    Ghilezan N
    Radiobiol Radiother (Berl); 1975; 16(3):271-7. PubMed ID: 1215486
    [No Abstract]   [Full Text] [Related]  

  • 5. [Radiation treatment of recurrences of laryngeal cancer].
    Morozov AI; Rogachikova TA; Deviatykh IuN
    Med Radiol (Mosk); 1975 Jun; 20(6):8-12. PubMed ID: 1143045
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fractionation of the daily dose (hyperfractionation) in telegammatherapy of laryngeal tumors].
    Mardynsky JuS ; Andreev VG; Sysoev AS
    Radiobiol Radiother (Berl); 1986; 27(4):407-12. PubMed ID: 3774995
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of dose distribution by time on the results of radioisotope teletherapy of malignant laryngeal neoplasms].
    Broisevich NV; Baĭmakanova SSh; Zholkiver KI; Rakhmetova AU
    Med Radiol (Mosk); 1974 Dec; 19(12):6-13. PubMed ID: 4444442
    [No Abstract]   [Full Text] [Related]  

  • 8. How can different prescribed doses give the same recurrence rate?
    Niederer J; Till JE
    Br J Radiol; 1977 Nov; 50(599):842-3. PubMed ID: 588911
    [No Abstract]   [Full Text] [Related]  

  • 9. [Our results in the conventional x-ray and radium contact irradiation of laryngeal neoplasms].
    Troceanu M; Kornmesser HJ
    Strahlentherapie; 1970 Sep; 140(3):252-67. PubMed ID: 4994766
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immediate results of use of bremsstrahlung betatron radiation of 25 Mev in the treatment of malignant laryngeal neoplasms].
    Kitsmaniuk ZD; Borozdina AV
    Vestn Otorinolaringol; 1973; 35(3):79-83. PubMed ID: 4204400
    [No Abstract]   [Full Text] [Related]  

  • 11. [Is it necessary to return to 200 kv radiotherapy in treatment of laryngeal and hypopharyngeal cancers?].
    Debain JJ; Freyss G; Duteil G; Poulain H
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac (1967); 1969 Dec; 18(10):799-800. PubMed ID: 4251575
    [No Abstract]   [Full Text] [Related]  

  • 12. Regarding Million's editorial on the "Relative clinical influence of tumor dose versus dose per fraction ... following larynx radiotherapy".
    Ramsay J
    Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):485. PubMed ID: 8407427
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of overall time and dose on the response of glottic carcinoma of the larynx to radiotherapy.
    Fowler JF; Chappell R
    Eur J Cancer; 1994; 30A(5):719-21. PubMed ID: 8080696
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical experience with different fractionation rhythm and single doses].
    Lessel A; Eichhorn HJ
    Radiobiol Radiother (Berl); 1972; 13(1):9-13. PubMed ID: 5035447
    [No Abstract]   [Full Text] [Related]  

  • 15. [Optimal dosimetry conditions at roentgenotherapy of malignant laryngeal tumors with the PYM-13 appliance].
    Khrapachevs'kiĭ VM
    Fiziol Zh; 1968; 14(3):409-10. PubMed ID: 5713876
    [No Abstract]   [Full Text] [Related]  

  • 16. Radiation tolerance of the normal tissues of the larynx. Its implications in radiotherapy.
    Aristizabal SA; Caldwell WL
    Radiology; 1972 May; 103(2):419-22. PubMed ID: 5024571
    [No Abstract]   [Full Text] [Related]  

  • 17. [Assessment of the radiosensitivity of laryngeal cancer].
    Smirnova IN
    Vestn Otorinolaringol; 1981; (3):70-4. PubMed ID: 7269051
    [No Abstract]   [Full Text] [Related]  

  • 18. Laryngeal cancer: practical problems in effective dose delivery.
    Cunningham JR; Van Dyk JV
    Laryngoscope; 1975 Jun; 85(6):1029-38. PubMed ID: 1142967
    [No Abstract]   [Full Text] [Related]  

  • 19. Radiation therapy of cancer of the vocal cord and NSD implications.
    Vaeth JM; Green JP; Schroeder AF
    Am J Roentgenol Radium Ther Nucl Med; 1972 Jan; 114(1):63-4. PubMed ID: 5009417
    [No Abstract]   [Full Text] [Related]  

  • 20. [Methods and results of radiotherapy in laryngeal neoplasms using 18 mev retarded rays. II. Dosage and results].
    Heinze HG; Dabelstein S
    Strahlentherapie Sonderb; 1969; 68():120-30. PubMed ID: 4976642
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.